insightsengineering / teal.modules.hermes

RNA-seq analysis modules to add to a teal application
https://insightsengineering.github.io/teal.modules.hermes/
Other
7 stars 1 forks source link

[Bug]: integration test failure #379

Closed BFalquet closed 5 months ago

BFalquet commented 5 months ago

What happened?

══ Failed tests ════════════════════════════════════════════════════════════════
  ── Failure ('test-assaySpec.R:39:3'): assaySpecServer module works as expected in the test app ──
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Failure ('test-assaySpec.R:46:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "rpkm" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('rpkm')
  ── Failure ('test-assaySpec.R:49:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"rpkm\"" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('[1] "rpkm"')
  ── Failure ('test-assaySpec.R:54:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"voom\"" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('[1] "voom"')
  ── Failure ('test-assaySpec.R:60:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"\"" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('[1] ""')
  ── Failure ('test-forest.R:40:3'): forest_tte module works as expected in the test app ──
  `res` (`actual`) not identical to "hd1" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('hd1')
  ── Failure ('test-forest.R:43:3'): forest_tte module works as expected in the test app ──
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Error ('test-forest.R:51:3'): forest_tte module works as expected in the test app ──
  Error in `app_wait_for_value(self, private, input = input, output = output, 
      export = export, ..., ignore = ignore, timeout = timeout, 
      interval = interval)`: timeout reached when waiting for input: NA-module-assay-name
  Backtrace:
      ▆
   1. └─app$wait_for_value(input = ns("assay-name")) at test-forest.R:51:3
   2.   └─shinytest2:::app_wait_for_value(...)
   3.     └─shinytest2:::app_abort(...)
   4.       └─rlang::abort(..., app = self, call = call)
  ── Failure ('test-km.R:41:3'): km module works as expected in the test app ─────
  `res` (`actual`) not identical to "hd1" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('hd1')
  ── Failure ('test-km.R:44:3'): km module works as expected in the test app ─────
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Failure ('test-km.R:51:3'): km module works as expected in the test app ─────
  `res` (`actual`) not identical to "cpm" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('cpm')
  ── Failure ('test-km.R:59:3'): km module works as expected in the test app ─────
  res$message (`actual`) not identical to "please select an endpoint" (`expected`).

  `actual` is NULL
  `expected` is a character vector ('please select an endpoint')
  ── Failure ('test-km.R:64:3'): km module works as expected in the test app ─────
  Snapshot of code has changed:
  old vs new
    Code
      cat(res)
  - Output
  -   $binned_adtte
  -                    USUBJID low_depth_flag tech_failure_flag Filename
  -   3   AB12345-CHN-1-id-307          FALSE             FALSE     eset
  -   9  AB12345-CHN-15-id-201          FALSE             FALSE     eset
  -   11   AB12345-CHN-4-id-73          FALSE             FALSE     eset
  -   18   AB12345-CHN-7-id-28          FALSE             FALSE     eset
  -   24 AB12345-NGA-11-id-173           TRUE             FALSE     eset
  -   30 AB12345-PAK-11-id-268          FALSE             FALSE     eset
  -   34   AB12345-RUS-1-id-52          FALSE             FALSE     eset
  -   39  AB12345-USA-1-id-261          FALSE             FALSE     eset
  -   41   AB12345-USA-1-id-45          FALSE             FALSE     eset
  -              AGEGRP AGE18                STDDRS
  -   3  12 - <18 years  < 18                 DEATH
  -   9     >= 18 years >= 18                 DEATH
  -   11  6 - <12 years  < 18                 DEATH
  -   18 12 - <18 years  < 18                      
  -   24  6 - <12 years  < 18                 DEATH
  -   30    >= 18 years >= 18 WITHDRAWAL BY SUBJECT
  -   34  6 - <12 years  < 18                 DEATH
  -   39 12 - <18 years  < 18                      
  -   41    >= 18 years >= 18                 DEATH
  -                                  STDDRSD    STDSSDT                TRTDRS
  -   3  DEATH DUE TO PROGRESSION OF DISEASE 07/24/2016   PROGRESSIVE DISEASE
  -   9  DEATH DUE TO PROGRESSION OF DISEASE 08/12/2016   PROGRESSIVE DISEASE
  -   11 DEATH DUE TO PROGRESSION OF DISEASE 04/19/2016   PROGRESSIVE DISEASE
  -   18                                                  PROGRESSIVE DISEASE
  -   24 DEATH DUE TO PROGRESSION OF DISEASE 09/11/2016   PROGRESSIVE DISEASE
  -   30               WITHDRAWAL BY SUBJECT 07/05/2016 WITHDRAWAL BY SUBJECT
  -   34 DEATH DUE TO PROGRESSION OF DISEASE 10/23/2016   PROGRESSIVE DISEASE
  -   39                                                  PROGRESSIVE DISEASE
  -   41 DEATH DUE TO PROGRESSION OF DISEASE 01/08/2016   PROGRESSIVE DISEASE
  -                     TRTDRSD BHDCIRC BHDCIRCU ADAFL BLANP BKPS BLKS BTANNER
  -   3  PROGRESSION OF DISEASE      NA              Y    NA   80   80      NA
  -   9  PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   11 PROGRESSION OF DISEASE      NA              Y    70   NA   70      NA
  -   18 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   24 PROGRESSION OF DISEASE      NA              Y    NA  100  100      NA
  -   30  WITHDRAWAL BY SUBJECT      NA              Y    70   NA   70      NA
  -   34 PROGRESSION OF DISEASE      NA              Y   100   NA  100      NA
  -   39 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   41 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -               FRPST   DURIDX    DURSAF     DURSUR LNTHRPY AENCIFL STUDYID
  -   3  POST-MENARCHAL 61.66735 1.6755647  5.1581109       5      NA AB12345
  -   9                 10.84189 0.9856263  3.0554415       4      NA AB12345
  -   11                45.66735 1.6755647  3.1540041      10      NA AB12345
  -   18 POST-MENARCHAL 19.54825 1.7412731  9.6919918       4      NA AB12345
  -   24                99.28542 3.5811088  6.3408624       7      NA AB12345
  -   30                16.09856 0.9856263  0.6899384       2      NA AB12345
  -   34  PRE-MENARCHAL       NA 1.6755647 10.9404517       3      NA AB12345
  -   39                41.62628 1.6755647 18.8583162       3      NA AB12345
  -   41                45.73306 0.6570842  2.2997947       2      NA AB12345
  -               RFSTDTC          RFENDTC         RFXSTDTC         RFXENDTC
  -   3  2016-03-10T14:05 2016-03-31T15:49 2016-03-10T14:05 2016-03-31T15:49
  -   9  2016-05-31T14:10 2016-05-31T14:10 2016-05-31T14:10 2016-05-31T14:10
  -   11 2016-01-25T14:15 2016-02-15T10:40 2016-01-25T14:15 2016-02-15T10:40
  -   18 2016-12-06T13:09 2016-12-29T15:46 2016-12-06T13:09 2016-12-29T15:46
  -   24 2016-03-21T15:40 2016-06-08T18:00 2016-03-21T15:40 2016-06-08T18:00
  -   30 2016-06-15T12:45 2016-06-15T12:45 2016-06-15T12:45 2016-06-15T12:45
  -   34 2015-12-01T12:25 2015-12-22T14:10 2015-12-01T12:25 2015-12-22T14:10
  -   39 2016-02-08T12:37 2016-02-29T14:15 2016-02-08T12:37 2016-02-29T14:15
  -   41 2015-11-05T11:00 2015-11-05T11:00 2015-11-05T11:00 2015-11-05T11:00
  -         RFICDTC   RFPENDTC     DTHDTC DTHFL SITEID  INVID AGE  AGEU SEX
  -   3  2016-02-18 2016-07-24 2016-07-24     Y 283495 223804  12 YEARS   F
  -   9  2016-05-11 2016-08-12 2016-08-12     Y 282087 468105  27 YEARS   F
  -   11 2016-01-14 2016-04-19 2016-04-19     Y 280959  20842  10 YEARS   F
  -   18 2016-11-28                             282703 301818  17 YEARS   M
  -   24 2016-03-02 2016-09-11 2016-09-11     Y 283497 241874   7 YEARS   F
  -   30 2016-06-14 2016-07-05                  283662 244110  19 YEARS   F
  -   34 2015-11-25 2016-10-23 2016-10-23     Y 283971 235545  11 YEARS   F
  -   39 2016-02-01                             281049 457179  16 YEARS   F
  -   41 2015-10-30 2016-01-08 2016-01-08     Y 283971 235545  19 YEARS   F
  -                           RACE                 ETHNIC ARMCD       ARM ACTARMCD
  -   3                      WHITE NOT HISPANIC OR LATINO  COH3  COHORT 3     COH3
  -   9                    UNKNOWN           NOT REPORTED COH9E COHORT 9E    COH9E
  -   11                   UNKNOWN           NOT REPORTED  COH3  COHORT 3     COH3
  -   18                   UNKNOWN           NOT REPORTED  COH2  COHORT 2     COH2
  -   24 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -   30                     ASIAN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -   34                     WHITE NOT HISPANIC OR LATINO COH7A COHORT 7A    COH7A
  -   39                     ASIAN NOT HISPANIC OR LATINO  COH1  COHORT 1     COH1
  -   41                   UNKNOWN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -        ACTARM COUNTRY      DMDTC DMDY BAGE BAGEU   BWT BWTU BHT BHTU     BBMI
  -   3  COHORT 3     CHN 2016-02-18  -21   12 YEARS  50.0   kg 157   cm 20.28480
  -   9  COHORT 9     CHN 2016-05-25   -6   27 YEARS  61.6   kg 173   cm 20.58204
  -   11 COHORT 3     CHN 2016-01-14  -11   10 YEARS  29.4   kg 148   cm 13.42221
  -   18 COHORT 2     CHN 2016-11-28   -8   17 YEARS  38.2   kg 151   cm 16.75365
  -   24 COHORT 6     NGA 2016-03-02  -19    7 YEARS  53.9   kg 176   cm 17.40057
  -   30 COHORT 6     PAK 2016-06-14   -1   19 YEARS  51.0   kg 152   cm 22.07410
  -   34 COHORT 7     RUS 2015-11-25   -6   11 YEARS  36.2   kg 130   cm 21.42012
  -   39 COHORT 1     USA 2016-02-01   -7   16 YEARS 104.7   kg 172   cm 35.39075
  -   41 COHORT 6     USA 2015-10-30   -6   19 YEARS  57.0   kg 172   cm 19.26717
  -      ITTFL SAFFL    INFCODT     RANDDT          TRTSDTC             TRTSDTM
  -   3      Y     Y 2016-02-18 2016-03-09 2016-03-10T14:05 2016-03-10 14:05:00
  -   9      Y     Y 2016-05-11 2016-05-31 2016-05-31T14:10 2016-05-31 14:10:00
  -   11     Y     Y 2016-01-14 2016-01-22 2016-01-25T14:15 2016-01-25 14:15:00
  -   18     Y     Y 2016-11-28 2016-12-02 2016-12-06T13:09 2016-12-06 13:09:00
  -   24     Y     Y 2016-03-02 2016-03-21 2016-03-21T15:40 2016-03-21 15:40:00
  -   30     Y     Y 2016-06-14 2016-06-15 2016-06-15T12:45 2016-06-15 12:45:00
  -   34     Y     Y 2015-11-25 2015-12-01 2015-12-01T12:25 2015-12-01 12:25:00
  -   39     Y     Y 2016-02-01 2016-02-03 2016-02-08T12:37 2016-02-08 12:37:00
  -   41     Y     Y 2015-10-30 2015-11-05 2015-11-05T11:00 2015-11-05 11:00:00
  -      TRTSTMF             TRTEDTM TRTETMF TRTDUR DISCSTUD DISCDEAT DISCAE DISTRTFL
  -   3        S 2016-03-31 16:55:59       S     22        Y        Y      N        Y
  -   9        S 2016-05-31 15:10:59       S      1        Y        Y      N        Y
  -   11       S 2016-02-15 11:10:59       S     22        Y        Y      N        Y
  -   18       S 2016-12-29 16:19:59       S     24        N        N      N        Y
  -   24       S 2016-06-08 18:30:59       S     80        Y        Y      N        Y
  -   30       S 2016-06-15 13:45:59       S      1        Y        N      N        Y
  -   34       S 2015-12-22 14:40:59       S     22        Y        Y      N        Y
  -   39       S 2016-02-29 14:48:59       S     22        N        N      N        Y
  -   41       S 2015-11-05 12:00:59       S      1        Y        Y      N        Y
  -      AEWITHFL     ALIVDT
  -   3         N 2016-07-24
  -   9         N 2016-08-12
  -   11        N 2016-04-19
  -   18        N 2017-09-19
  -   24        N 2016-09-11
  -   30        N 2016-07-05
  -   34        N 2016-10-23
  -   39        N 2017-08-28
  -   41        N 2016-01-08
  -                                                             COHORT
  -   3                                       Cohort 3 (NEUROBLASTOMA)
  -   9  Cohort 9 (OTHER TUMOR TYPES WITH DOCUMENTED PD-L1 EXPRESSION)
  -   11                                      Cohort 3 (NEUROBLASTOMA)
  -   18                                   Cohort 2 (HODGKIN LYMPHOMA)
  -   24                                       Cohort 6 (OSTEOSARCOMA)
  -   30                                       Cohort 6 (OSTEOSARCOMA)
  -   34                                  Cohort 7 (RHABDOMYOSARCOMA )
  -   39                                      Cohort 1 (EWING SARCOMA)
  -   41                                       Cohort 6 (OSTEOSARCOMA)
  -                                                                                           TTYPE
  -   3                                                                               NEUROBLASTOMA
  -   9  GERM CELL TUMOR - YOLK SAC TUMOR (ENDODERMAL SINUS TUMOR) WITH DOCUMENTED PD-L1 EXPRESSION
  -   11                                                                              NEUROBLASTOMA
  -   18                                                                           HODGKIN LYMPHOMA
  -   24                                                                               OSTEOSARCOMA
  -   30                                                                               OSTEOSARCOMA
  -   34                                                                RHABDOMYOSARCOMA - ALVEOLAR
  -   39                                                                              EWING SARCOMA
  -   41                                                                               OSTEOSARCOMA
  -      STDSSDY                SUBJID Mean.ABCF2..ABO.         INVNAM         TRT01P
  -   3      137  AB12345-CHN-1-id-307         7.673103  Dr. CHN-1 Doe     B: Placebo
  -   9       74 AB12345-CHN-15-id-201         7.433943 Dr. CHN-15 Doe C: Combination
  -   11      86   AB12345-CHN-4-id-73         7.856089  Dr. CHN-4 Doe      A: Drug X
  -   18      NA   AB12345-CHN-7-id-28         7.454552  Dr. CHN-7 Doe     B: Placebo
  -   24     175 AB12345-NGA-11-id-173         7.702519 Dr. NGA-11 Doe C: Combination
  -   30      21 AB12345-PAK-11-id-268         7.324474 Dr. PAK-11 Doe      A: Drug X
  -   34     328   AB12345-RUS-1-id-52         7.410471  Dr. RUS-1 Doe      A: Drug X
  -   39      NA  AB12345-USA-1-id-261         7.662349  Dr. USA-1 Doe     B: Placebo
  -   41      65   AB12345-USA-1-id-45         7.780904  Dr. USA-1 Doe      A: Drug X
  -              TRT01A     TRT02P         TRT02A       REGION1 STRATA1 STRATA2
  -   3      B: Placebo B: Placebo C: Combination          Asia       C      S1
  -   9  C: Combination B: Placebo C: Combination          Asia       C      S2
  -   11      A: Drug X B: Placebo C: Combination          Asia       A      S1
  -   18     B: Placebo B: Placebo     B: Placebo          Asia       C      S2
  -   24 C: Combination B: Placebo      A: Drug X        Africa       C      S2
  -   30      A: Drug X B: Placebo      A: Drug X          Asia       C      S2
  -   34      A: Drug X B: Placebo C: Combination       Eurasia       C      S2
  -   39     B: Placebo B: Placebo     B: Placebo North America       C      S1
  -   41      A: Drug X  A: Drug X      A: Drug X North America       C      S1
  -          BMRKR1 BMRKR2 BMEASIFL BEP01FL           TRT01SDTM           TRT01EDTM
  -   3   4.5749910    LOW        Y       N 2019-03-11 08:01:26 2021-02-18 02:48:40
  -   9   6.9067988 MEDIUM        Y       N 2019-03-05 15:24:07 2021-02-18 22:06:48
  -   11  2.8631240 MEDIUM        Y       Y 2019-03-17 14:18:17 2021-02-14 13:35:43
  -   18 11.1444470 MEDIUM        N       N 2019-03-11 09:11:52 2021-03-10 21:11:52
  -   24  4.9972257    LOW        Y       Y 2019-03-10 09:35:30 2021-03-09 21:35:30
  -   30  2.8201408 MEDIUM        N       N 2019-03-21 23:53:53 2021-03-21 11:53:53
  -   34  7.2063482   HIGH        N       N 2019-03-18 09:38:55 2021-02-13 06:30:28
  -   39  2.8551642   HIGH        Y       N 2019-03-06 17:21:21 2021-03-06 05:21:21
  -   41  0.4635604    LOW        N       N 2019-03-06 06:32:29 2021-03-05 18:32:29
  -                TRT02SDTM           TRT02EDTM            AP01SDTM
  -   3  2021-02-18 02:48:40 2022-02-18 08:48:40 2019-03-11 08:01:26
  -   9  2021-02-18 22:06:48 2022-02-19 04:06:48 2019-03-05 15:24:07
  -   11 2021-02-14 13:35:43 2022-02-14 19:35:43 2019-03-17 14:18:17
  -   18 2021-03-10 21:11:52 2022-03-11 03:11:52 2019-03-11 09:11:52
  -   24 2021-03-09 21:35:30 2022-03-10 03:35:30 2019-03-10 09:35:30
  -   30 2021-03-21 11:53:53 2022-03-21 17:53:53 2019-03-21 23:53:53
  -   34 2021-02-13 06:30:28 2022-02-13 12:30:28 2019-03-18 09:38:55
  -   39 2021-03-06 05:21:21 2022-03-06 11:21:21 2019-03-06 17:21:21
  -   41 2021-03-05 18:32:29 2022-03-06 00:32:29 2019-03-06 06:32:29
  -                 AP01EDTM            AP02SDTM            AP02EDTM       EOSSTT
  -   3  2021-02-18 02:48:40 2021-02-18 02:48:40 2022-02-18 08:48:40 DISCONTINUED
  -   9  2021-02-18 22:06:48 2021-02-18 22:06:48 2022-02-19 04:06:48 DISCONTINUED
  -   11 2021-02-14 13:35:43 2021-02-14 13:35:43 2022-02-14 19:35:43 DISCONTINUED
  -   18 2021-03-10 21:11:52 2021-03-10 21:11:52 2022-03-11 03:11:52    COMPLETED
  -   24 2021-03-09 21:35:30 2021-03-09 21:35:30 2022-03-10 03:35:30    COMPLETED
  -   30 2021-03-21 11:53:53 2021-03-21 11:53:53 2022-03-21 17:53:53    COMPLETED
  -   34 2021-02-13 06:30:28 2021-02-13 06:30:28 2022-02-13 12:30:28 DISCONTINUED
  -   39 2021-03-06 05:21:21 2021-03-06 05:21:21 2022-03-06 11:21:21    COMPLETED
  -   41 2021-03-05 18:32:29 2021-03-05 18:32:29 2022-03-06 00:32:29    COMPLETED
  -            EOTSTT      EOSDT EOSDY          DCSREAS      DTHDT
  -   3  DISCONTINUED 2022-02-18  1076            DEATH 2022-04-06
  -   9  DISCONTINUED 2022-02-19  1082            DEATH 2022-02-22
  -   11 DISCONTINUED 2022-02-14  1066 LACK OF EFFICACY       <NA>
  -   18    COMPLETED 2022-03-11  1096             <NA>       <NA>
  -   24    COMPLETED 2022-03-10  1096             <NA>       <NA>
  -   30    COMPLETED 2022-03-21  1096             <NA>       <NA>
  -   34 DISCONTINUED 2022-02-13  1064            DEATH 2022-02-20
  -   39    COMPLETED 2022-03-06  1096             <NA>       <NA>
  -   41    COMPLETED 2022-03-06  1096             <NA>       <NA>
  -                  DTHCAUS              DTHCAT LDDTHELD LDDTHGR1   LSTALVDT DTHADY
  -   3    LOST TO FOLLOW UP               OTHER       47      >30 2022-04-06   1121
  -   9        ADVERSE EVENT       ADVERSE EVENT        3     <=30 2022-02-22   1084
  -   11                <NA>                <NA>       NA     <NA> 2022-03-07     NA
  -   18                <NA>                <NA>       NA     <NA> 2022-03-31     NA
  -   24                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -   30                <NA>                <NA>       NA     <NA> 2022-04-02     NA
  -   34 DISEASE PROGRESSION PROGRESSIVE DISEASE        7     <=30 2022-02-20   1069
  -   39                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -   41                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -      ADTHAUT ASEQ TTESEQ                     PARAM PARAMCD      AVAL AVALU
  -   3     <NA>    4      4 Progression Free Survival     PFS 239.08590  DAYS
  -   9      Yes    2      2 Progression Free Survival     PFS 248.53707  DAYS
  -   11    <NA>    3      3 Progression Free Survival     PFS 420.38459  DAYS
  -   18    <NA>    3      3 Progression Free Survival     PFS  30.04978  DAYS
  -   24    <NA>    2      2 Progression Free Survival     PFS 382.86110  DAYS
  -   30    <NA>    1      1 Progression Free Survival     PFS 326.40156  DAYS
  -   34     Yes    1      1 Progression Free Survival     PFS  45.07870  DAYS
  -   39    <NA>    2      2 Progression Free Survival     PFS 899.41424  DAYS
  -   41    <NA>    3      3 Progression Free Survival     PFS 131.76520  DAYS
  -                     ADTM  ADY CNSR                    EVNTDESC
  -   3  2022-02-16 08:01:26 1073    1       Last Tumor Assessment
  -   9  2020-04-05 15:24:07  397    0         Disease Progression
  -   11 2020-09-20 14:18:17  553    0                       Death
  -   18 2020-10-02 09:11:52  571    1 Last Date Known To Be Alive
  -   24 2021-09-04 09:35:30  909    0         Disease Progression
  -   30 2019-12-14 23:53:53  268    1       Last Tumor Assessment
  -   34 2019-11-14 09:38:55  241    0         Disease Progression
  -   39 2020-07-15 17:21:21  497    0                       Death
  -   41 2020-06-28 06:32:29  480    0                       Death
  -                        CNSDTDSC lgTMATRSK is_event gene_factor
  -   3            Clinical Cut Off        NA    FALSE  (50%,100%]
  -   9                                    NA     TRUE    [0%,50%]
  -   11                                   NA     TRUE  (50%,100%]
  -   18           Clinical Cut Off        NA    FALSE    [0%,50%]
  -   24                                   NA     TRUE  (50%,100%]
  -   30 End of AE Reporting Period        NA    FALSE    [0%,50%]
  -   34                                   NA     TRUE    [0%,50%]
  -   39                                   NA     TRUE    [0%,50%]
  -   41                                   NA     TRUE  (50%,100%]
  -   
  -   $variables
  -   $variables$tte
  -   [1] "AVAL"
  -   
  -   $variables$is_event
  -   [1] "is_event"
  -   
  -   $variables$arm
  -   [1] "gene_factor"
  -   
  -   $variables$strat
  -   NULL

  * Run `testthat::snapshot_accept('km')` to accept the change.
  * Run `testthat::snapshot_review('km')` to interactively review the change.
  ── Error ('test-pca.R:76:3'): pca module works as expected in the test app ─────
  Error in `app_find_node_id(self, private, input = input, output = output, 
      selector = selector)`: Cannot find HTML element with selector #teal-main_ui-filter_panel-active-MAE-hd1-MAE_symbol_hd1_subset-remove.shiny-bound-input
  Backtrace:
      ▆
   1. └─app$click(ns2("active-MAE-hd1-MAE_symbol_hd1_subset-remove")) at test-pca.R:76:3
   2.   └─shinytest2:::app_click(...)
   3.     └─shinytest2:::app_find_node_id(self, private, input = input, output = output, selector = selector)
   4.       └─shinytest2:::app_abort(...)
   5.         └─rlang::abort(..., app = self, call = call)

  [ FAIL 14 | WARN 0 | SKIP 0 | PASS 169 ]
  Error: Test failures
  Execution halted
* checking PDF version of manual ... OK
* DONE

sessionInfo()

No response

Relevant log output

No response

Code of Conduct

Contribution Guidelines

Security Policy